Final answer:
The diagnosis is likely Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease that can cause erythema nodosum. Treatment involves anti-inflammatory medications, immunosuppressants, and antimalarials like hydroxychloroquine.
Step-by-step explanation:
The case described is suggestive of Systemic Lupus Erythematosus (SLE), particularly considering the mention of hilar Lymphadenopathy (LAD), increased Angiotensin-Converting Enzyme (ACE), and the presence of erythema nodosum. SLE is a chronic inflammatory disease that presents with various symptoms, often affecting the skin, joints, kidneys, and other organs.
The presentation of erythema nodosum, which involves red nodules on the skin typically on the legs or face, coupled with the patient being a young African American female aligns with the demographic that is commonly affected by SLE. Erythema nodosum is an inflammatory condition affecting the subcutaneous fat cells of the hypodermis, resulting in red, tender nodules.
Treatment for SLE typically includes a combination of pharmacological and supportive therapies, which may involve anti-inflammatory medications, immunosuppressants, and antimalarial drugs such as hydroxychloroquine. It is crucial for ongoing monitoring and supportive care to manage this complex autoimmune disorder effectively. Given the potential complications associated with SLE, a multidisciplinary approach is often required for comprehensive care.